0000947871-13-000099.txt : 20130214 0000947871-13-000099.hdr.sgml : 20130214 20130214060851 ACCESSION NUMBER: 0000947871-13-000099 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20130214 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADVANTEST CORP CENTRAL INDEX KEY: 0001158838 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15236 FILM NUMBER: 13606041 BUSINESS ADDRESS: STREET 1: SHIN-MARUNOUCHI CENTER BUILDING STREET 2: 1-6-2 MARUNOUCHI, CITY: CHIYODA-KU, TOKYO 100-0005 STATE: M0 ZIP: 00000 BUSINESS PHONE: 81-3-3214-7500 MAIL ADDRESS: STREET 1: SHIN-MARUNOUCHI CENTER BUILDING STREET 2: 1-6-2 MARUNOUCHI, CITY: CHIYODA-KU, TOKYO 100-0005 STATE: M0 ZIP: 00000 6-K 1 ss164887_6k.htm REPORT OF FOREIGN PRIVATE ISSUER



FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Private Issuer


Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934


For the month of February 2013

Commission File Number 1-15236

Advantest Corporation
(Translation of Registrant’s Name Into English)

Shin Marunouchi Center Building
1-6-2, Marunouchi
Chiyoda-ku
Tokyo 100-0005
Japan
(Address of Principal Executive Offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.  Form 20-F x  Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):               

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):               

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  Yes o  No x
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
 


 
 
 
 

Materials Contained in this Report:


 
1.
Executive summary of the Japanese-language Quarterly Report, submitted by the registrant to the Director-General of the Kanto Local Finance Bureau of the Ministry of Finance of Japan on February 14, 2013.

 
2.
English-language translation of the registrant’s Quarterly Consolidated Financial Statements for the fiscal third quarter ended December 31, 2012, filed with the Director-General of the Kanto Local Finance Bureau as part of the registrant’s Quarterly Report.




 
 
 
 
 
 
 
 
 

 
 
 

 
 
SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
  Advantest Corporation  
         
         
         
  By:  /s/ Hiroshi Nakamura  
    Name: Hiroshi Nakamura  
    Title: Director, Managing Executive Officer  
         

 
Date:  February 14, 2013







 



 

EX-99.1 2 ss164887_ex9901.htm EXECUTIVE SUMMARY OF QUARTERLY REPORT
 
Executive Summary Quarterly Report
Exhibit 1

Japanese Quarterly Report for the fiscal third quarter ended December 31, 2012, submitted to the Director-General of the Kanto Local Finance Bureau of the Ministry of Finance of Japan on February 14, 2013, which included the following information:

I. 
Corporate Information

 
1.
Corporate Overview
 
·
Significant financial indices
 
·
Business overview

 
2.
Business Information
 
·
Risk factors
 
·
Material agreements
 
·
Operating and financial review and prospects

 
3.
Company Data
 
·
Share information
 
-
Total number of shares
 
Stock acquisition rights
 
Bonds with stock acquisition rights with contingently adjustable exercise price (none)
 
Rights plan (none)
 
Number of shares outstanding, changes in capital stock
 
Major shareholders
 
Voting rights
 
·
Changes in directors and corporate auditors

 
4.
Financial information
 
·
Consolidated financial statements (Unaudited)
 
·
Others

II.  Information on Guarantors (none)

Quarterly review report

Exhibit
Certifications of the Registrant’s Representative Director, President and Chief Executive Officer
 
 
 
 

EX-99.2 3 ss164887_ex9902.htm THIRD QUARTER FINANCIAL RESULTS
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
             
Consolidated Balance Sheets (Unaudited)
             
             
             
   
Yen (Millions)
 
Assets
 
March 31, 2012
   
December 31, 2012
 
             
Current assets:
           
Cash and cash equivalents
  ¥ 58,218       43,610  
Trade receivables, net
    24,119       23,226  
Inventories
    29,836       34,629  
Other current assets
    6,522       8,372  
                 
Total current assets
    118,695       109,837  
                 
                 
Investment securities
    5,929       5,090  
Property, plant and equipment, net of accumulated
    34,206       39,281  
depreciation of 39,386 million yen and 40,633 million yen,
               
as of March 31, 2012 and December 31, 2012, respectively
               
Intangible assets, net of accumulated
    15,794       15,134  
amortization of 3,380 million yen and 5,151 million yen,
               
as of March 31, 2012 and December 31, 2012, respectively
               
Goodwill
    36,496       38,411  
Other assets
    8,106       8,340  
                 
Total assets
  ¥ 219,226       216,093  
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 1 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Consolidated Balance Sheets (Unaudited)
 
 
 
   
Yen (Millions)
 
Liabilities and Stockholders’ Equity
 
March 31, 2012
   
December 31, 2012
 
             
Current liabilities:
           
Trade accounts payable
  ¥ 15,659       11,892  
Short term debt
    25,000        
Accrued expenses
    12,068       6,846  
Accrued warranty expenses
    2,129       1,934  
Customer prepayments
    2,228       2,424  
Other current liabilities
    3,288       5,904  
                 
Total current liabilities
    60,372       29,000  
                 
Corporate bonds
          25,000  
Accrued pension and severance costs
    23,444       24,045  
Other liabilities
    3,858       3,639  
                 
Total liabilities
    87,674       81,684  
                 
Commitments and contingent liabilities
               
                 
Stockholders’ equity:
               
Common stock,
               
Authorized 440,000,000 shares; issued 199,566,770 shares
    32,363       32,363  
Capital surplus
    42,280       42,634  
Retained earnings
    179,081       172,930  
Accumulated other comprehensive income (loss)
    (22,574 )     (15,199 )
Treasury stock, 26,295,390 shares and 25,958,093 shares
               
as of March 31, 2012 and December 31, 2012, respectively
    (99,598 )     (98,319 )
                 
Total stockholders’ equity
    131,552       134,409  
                 
Total liabilities and stockholders’ equity
  ¥ 219,226       216,093  
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 2 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
             
Consolidated Statements of Operations (Unaudited)
             
             
             
             
   
Yen (Millions)
 
   
Nine months ended
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
             
Net sales
  ¥ 95,155       97,186  
Cost of sales
    51,498       46,049  
                 
Gross profit
    43,657       51,137  
                 
Research and development expenses
    21,512       24,200  
Selling, general and administrative expenses
    27,468       26,113  
                 
Operating income (loss)
    (5,323 )     824  
                 
Other income (expense):
               
Interest and dividend income
    291       159  
Interest expense
    (110 )     (97 )
Other, net
    (2,947 )     (778 )
                 
Total other income (expense)
    (2,766 )     (716 )
                 
Income (loss) before income taxes and equity
               
in earnings (loss) of affiliated company
    (8,089 )     108  
                 
Income tax expense (benefit)
    (358 )     2,059  
Equity in earnings (loss) of affiliated company
    (1 )     34  
                 
Net income (loss)
  ¥ (7,732 )     (1,917 )
                 
                 
                 
                 
   
Yen
 
   
Nine months ended
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
                 
Net income (loss) per share:
               
Basic
  ¥ (44.62 )     (11.05 )
Diluted
    (44.62 )     (11.05 )
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 3 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
             
Consolidated Statements of Operations (Unaudited)
             
             
             
             
   
Yen (Millions)
 
   
Three months ended
   
Three months ended
 
   
December 31, 2011
   
December 31, 2012
 
             
Net sales
  ¥ 30,695       24,628  
Cost of sales
    17,299       11,551  
                 
Gross profit
    13,396       13,077  
                 
Research and development expenses
    7,688       7,526  
Selling, general and administrative expenses
    8,748       8,096  
                 
Operating income (loss)
    (3,040 )     (2,545 )
                 
Other income (expense):
               
Interest and dividend income
    106       68  
Interest expense
    (44 )     (37 )
Other, net
    (438 )     (495 )
                 
Total other income (expense)
    (376 )     (464 )
                 
Income (loss) before income taxes and equity
               
in earnings (loss) of affiliated company
    (3,416 )     (3,009 )
                 
Income tax expense (benefit)
    (189 )     431  
Equity in earnings of affiliated company
    34       4  
                 
Net income (loss)
  ¥ (3,193 )     (3,436 )
                 
                 
                 
                 
   
Yen
 
   
Three months ended
   
Three months ended
 
   
December 31, 2011
   
December 31, 2012
 
                 
Net income (loss) per share:
               
Basic
  ¥ (18.43 )     (19.80 )
Diluted
    (18.43 )     (19.80 )
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 4 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
 
 
 
   
Yen (Millions)
   
Nine months ended
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
             
Comprehensive income (loss)
           
Net income (loss)
  ¥ (7,732 )     (1,917 )
Other comprehensive income (loss), net of tax
               
Foreign currency translation adjustments
    (4,975 )     7,345  
Net unrealized gains (losses) on investment securities
               
Net unrealized gains (losses) arising
               
during the period
    (1,076 )     (605 )
Less reclassification adjustments for net
               
gains (losses) realized in earnings
    813       251  
Net unrealized gains (losses)
    (263 )     (354 )
                 
Pension related adjustments
    165       384  
Net unrealized gains (losses) on derivative instruments
    (63 )     -  
                 
Total other comprehensive income (loss)
    (5,136 )     7,375  
                 
Total comprehensive income (loss)
  ¥ (12,868 )     5,458  
                 
                 
   
Yen (Millions)
 
   
Three months ended
   
Three months ended
 
   
December 31, 2011
   
December 31, 2012
 
                 
Comprehensive income (loss)
               
Net income (loss)
  ¥ (3,193 )     (3,436 )
Other comprehensive income (loss), net of tax
               
Foreign currency translation adjustments
    1,109       13,201  
Net unrealized gains (losses) on investment securities
               
Net unrealized gains (losses) arising
               
during the period
    54       208  
Less reclassification adjustments for net
               
gains (losses) realized in earnings
    128       -  
Net unrealized gains (losses)
    182       208  
                 
Pension related adjustments
    11       (23 )
Net unrealized gains (losses) on derivative instruments
    2       -  
                 
Total other comprehensive income (loss)
    1,304       13,386  
                 
Total comprehensive income (loss)
  ¥ (1,889 )     9,950  
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 5 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
             
Consolidated Statements of Cash Flows (Unaudited)
             
             
   
Yen (Millions)
 
   
Nine months ended
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
             
Cash flows from operating activities: 
           
Net income (loss)
  ¥ (7,732 )     (1,917 )
Adjustments to reconcile net income (loss) to net cash
               
provided by (used in) operating activities:
               
Depreciation and amortization
    4,958       5,828  
Deferred income taxes
    (1,186 )     (449 )
Stock option compensation expense
    408       581  
Impairment losses on investment securities
    1,454       388  
Changes in assets and liabilities:
               
Trade receivables
    6,202       2,201  
Inventories
    444       (3,980 )
Trade accounts payable
    (325 )     (4,624 )
Accrued expenses
    (2,308 )     (5,296 )
Accrued pension and severance costs
    179       952  
Other
    3,240       2,980  
                 
Net cash provided by (used in) operating activities
    5,334       (3,336 )
                 
Cash flows from investing activities:
               
(Increase) decrease in short-term investments
    14,375       -  
Proceeds from sale of available-for-sale securities
    10,262       -  
Acquisition of subsidiary, net of cash acquired
    (57,145 )     -  
Proceeds from sale of property, plant and equipment
    67       30  
Purchases of property, plant and equipment
    (4,303 )     (9,527 )
Purchases of intangible assets
    (234 )     (323 )
Other
    34       201  
                 
Net cash provided by (used in) investing activities  
    (36,944 )     (9,619 )
                 
Cash flows from financing activities: 
               
Increase (decrease) in short term debt
    41,146       (25,000 )
Proceeds from issuance of corporate bonds
    -       25,000  
Redemption of senior convertible notes of acquired subsidiary
    (13,742 )     -  
Dividends paid
    (1,678 )     (3,356 )
Other
    (12 )     334  
                 
Net cash provided by (used in) financing activities
    25,714       (3,022 )
                 
Net effect of exchange rate changes on cash and cash equivalents
    (4,037 )     1,369  
                 
Net change in cash and cash equivalents
    (9,933 )     (14,608 )
                 
Cash and cash equivalents at beginning of period
    75,323       58,218  
                 
Cash and cash equivalents at end of period
  ¥ 65,390       43,610  
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012, are an integral part of the consolidated financial statements.
 
 
- 6 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
 
(1)
Accounting Principles, Procedures and the Presentation of the Consolidated Financial Statements

 
(a) 
Terminology, Form and Method of Preparation of the Consolidated Financial Statements

Advantest Corporation (the “Company”) and its consolidated subsidiaries (collectively, “Advantest”) prepare its consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).  U.S. GAAP is codified in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities.
Advantest prepared the accompanying interim consolidated financial statements in conformity with U.S. GAAP, consistent in all material respects with those applied in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012.
The interim financial statements are unaudited, but reflect all normal adjustments that are, in the opinion of management, necessary to provide a fair presentation of results for the interim periods presented.  This interim information should be read with the consolidated financial statements in Advantest’s Annual Report on Form 20-F/A (Amendment No.1) for the year ended March 31, 2012.

 
(b) 
Preparation of the Consolidated Financial Statements and Registration with the U.S. Securities and Exchange Commission

The Company became listed on the New York Stock Exchange on September 17, 2001 (local time) by means of an issuance of American Depository Shares, and has been filing a Form 20-F (equivalent to the Annual Securities Report in Japan) with the U.S. Securities and Exchange Commission since the year ended March 31, 2002.  Advantest prepares the consolidated financial statements in its Form 20-F in accordance with U.S. GAAP.

 
(c) 
Significant differences from the preparation of financial statements under Japanese GAAP

Of the accounting principles, procedures and method of presentation adopted by Advantest, the following is a brief summary description of the significant differences from the preparation of financial statements using the accounting principles, procedures and methods of presentation under Japanese GAAP, as required under the Financial Instruments and Exchange Law of Japan:

(i) Allowance for compensated absences
An allowance is provided for the right of employees to receive compensated absences in the future.

(ii) Accrued pension and severance costs
The funded status, which is the difference between the fair value of plan assets and the projected benefit obligation, of pension plans is recognized in the consolidated balance sheets.

(iii) Business Combination
Goodwill arising from business combination is not amortized, but instead is tested for impairment at least annually. Acquisition related costs are expensed as incurred.
 
 
- 7 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
(iv) Stock option
Expired unused gains from stock based compensation are not recognized in the case of expiration of stock option.

(2)
Description of Business and Summary of Significant Accounting Policies and Practices
 
 
(a)
Description of Business
 
Advantest manufactures and sells semiconductor and component test system products and mechatronics-related products such as test handlers and device interfaces.  Advantest also engages in research and development activities and provides maintenance and support services associated with these products.

Description of the business by segment is as follows:

The semiconductor and component test system segment provides customers with test system products for the semiconductor industry and the electronic parts industry.  Product lines provided in the semiconductor and component test system segment include test systems for memory semiconductors for memory semiconductor devices and test systems for SoC (“System-on-a-Chip”) semiconductors for non memory semiconductor devices.

The mechatronics system segment provides product lines such as test handlers, mechatronic-applied products for handling semiconductor devices, device interfaces that serve as interfaces with the devices that are measured and operations related to nano-technology products.

The services, support and others segment consists of comprehensive customer solutions provided in connection with the above segments, support services, equipment lease business and others.
 

 
(b)
Accounting Changes and Accounting Standards Not Yet Adopted
 
In June 2011, the FASB amended the accounting guidance for the presentation of comprehensive income. This new guidance eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders’ equity and provides the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB deferred the effective date for presentation of reclassifications out of accumulated other comprehensive income. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The guidance was adopted by Advantest in the first quarter beginning April 1, 2012. The adoption of the guidance did not have a significant impact on its consolidated results of operations and financial condition.
 
 
- 8 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
In February 2013, the FASB finalized the accounting guidance for reporting of amounts reclassified out of accumulated other comprehensive income. This new guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. The guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2012, with early adoption permitted. The guidance is required to be adopted by Advantest in the first quarter beginning April 1, 2013. Advantest is currently evaluating the timing and the effect that this adoption will have on its consolidated results of operations and financial condition.

In September 2011, the FASB amended the accounting guidance for testing goodwill for impairment. This new guidance gives entities the option to perform the two-step process only if they first perform a qualitative assessment and conclude that it is more likely than not (a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount. The guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 with early adoption permitted. The guidance was adopted by Advantest in the first quarter beginning April 1, 2012.  The adoption of the guidance did not have a significant impact on its consolidated results of operations and financial condition.

In July 2012, the FASB amended the accounting guidance to simplify how entities test indefinite-lived intangible assets for impairment which improve consistency in impairment testing requirements among long-lived asset categories.  The guidance permits an assessment of qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value.  For assets in which this assessment concludes it is more likely than not that the fair value is more than its carrying value, the guidance eliminates the requirement to perform quantitative impairment testing as outlined in the previously issued standards.  The guidance is effective for fiscal years beginning on or after September 16, 2012, with early adoption permitted.  The guidance is required to be adopted by Advantest in the first quarter beginning April 1, 2013.  Advantest is currently evaluating the timing and the effect that this adoption will have on its consolidated results of operations and financial condition.
 
 
(c)
Reclassification
 
Certain reclassifications have been made to the prior fiscal year’s consolidated financial statements to conform to the current quarter and year-to-date presentation.




 
- 9 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
(3)
Business Combinations
 
On July 4, 2011, Advantest acquired all outstanding ordinary shares of Verigy Ltd. (“Verigy”), for US$15.00 per share in cash.  Verigy became a wholly-owned subsidiary of Advantest.  In addition, as part of the consideration in the acquisition, Advantest assumed the obligation for stock options which had been granted by Verigy to certain directors and employees.

Summary of the total purchase price is as follows.
 
Yen (Millions)
Cash paid
77,661
Assumed stock options
1,068
Total purchase price
78,729
 
Acquisition-related costs for the nine months ended December 31, 2011 were ¥1,285 million and there were no acquisition-related costs for the three months ended December 31, 2011.  These costs were included in “Selling, general and administrative expenses” in the consolidated statements of operations.
 
Verigy has historically been strong in the non-memory tester and research and development markets in North America and Europe.  The complementary strengths in products, customer base, research and development, sales and service are expected to enhance combined company’s competitiveness in the global market.  The acquisition will allow Advantest to provide more and better diversified solutions to its customers in the semiconductor test equipment sector.

This acquisition was accounted for using the acquisition method.

The table below summarizes the allocation of the purchase price based on the fair value of assets acquired and liabilities assumed as follows.
 
Yen (Millions)
Assets acquired and liabilities assumed
 
Cash and cash equivalents
20,516
Trade receivable, net
2,104
Inventories
11,013
Property, plant and equipment
3,316
Intangible assets
16,899
Goodwill
35,140
Other assets
20,145
Trade accounts payable
(3,136)
Other liabilities
(27,268)
Net assets acquired
78,729
Purchase Price
78,729
Goodwill recognized is attributable primarily to expected synergies from combining operations of Verigy and Advantest.  None of the goodwill is expected to be deductible for income tax purposes.
 
 
- 10 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
 
The following represents the unaudited pro forma results of operations of Verigy for the nine months ended December 31, 2011, as if the acquisition of Verigy had occurred on April 1, 2010. The pro forma information does not necessarily reflect the actual results of operations had the acquisition been consummated at April 1, 2010, nor is it necessarily indicative of future operating results. The pro forma information does not give effect to any potential revenue enhancements, cost synergies or other operating efficiencies that could result from the acquisition (other than those realized subsequent to the July 4, 2011 acquisition date).
 
 
Yen (Millions)
 
Nine months ended
December 31, 2011
Pro forma net sales
104,001
Pro forma income (loss) before income taxes
(6,798)

(4)
Inventories
Inventories at March 31, 2012 and December 31, 2012 were composed of the following:

   
Yen (Millions)
 
   
March 31, 2012
   
December 31, 2012
 
             
Finished goods
  ¥ 8,318       8,000  
Work in process
    11,303       12,238  
Raw materials and supplies
    10,215       14,391  
                 
    ¥ 29,836       34,629  





 
- 11 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 

(5)
Investment Securities
 
Marketable equity securities are classified as available-for-sale securities.  The acquisition cost, gross unrealized gains, gross unrealized losses and fair value at March 31, 2012 and December 31, 2012 were as follows:
 

   
Yen (Millions)
 
   
March 31, 2012
 
       
   
Acquisition
cost
   
Gross
unrealized gains
   
Gross
unrealized losses
   
Fair value
 
Noncurrent:
                       
Available-for-sale:
                       
Equity securities
  ¥ 3,422       2,248       191       5,479  
 
 
   
Yen (Millions)
 
   
December 31, 2012
 
       
   
Acquisition
cost
   
Gross
unrealized gains
   
Gross
unrealized losses
   
Fair value
 
Noncurrent:
                               
Available-for-sale:
                               
Equity securities
  ¥ 3,086       1,606       52       4,640  
 

Equity securities consist primarily of stocks issued by Japanese listed companies.

Proceeds from the sale of available-for-sale securities for the nine months and three months ended December 31, 2011 were ¥10,262 million and ¥500 million.  Gross realized gains on available-for-sales securities for the nine months ended December 31, 2011 were ¥19 million. Gross realized gains on available-for-sales securities for the three months ended December 31, 2011 were insignificant.  No gross losses were realized on the sale of available-for-sale securities.  No proceeds from the sale of available-for-sale securities and no gross gains and losses were realized on the sale of available-for-sale securities for the nine months and three months ended December 31, 2012.

Net realized gains and losses of the sale of available-for-sale securities are based on the averaged cost method and are included in “other income (expense)” in the consolidated statements of operations.

For the nine months and three months ended December 31, 2011, Advantest recognized impairment losses of ¥1,259 million and ¥109 million on available-for-sale securities, which were considered other-than-temporarily impaired.  For the nine months and three months ended December 31, 2012, Advantest recognized impairment losses of ¥388 million and nil on available-for-sale securities, which were considered other-than-temporarily impaired.

Gross unrealized losses on available-for-sale securities and the fair value of the related securities, aggregated by length of time that individual securities have been in a continuous unrealized loss position, at March 31, 2012 and December 31, 2012, were as follows:
 
 
- 12 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
   
Yen (Millions)
 
   
March 31, 2012
 
   
Less than 12 months
   
12 months or longer
 
   
Fair value
   
Gross
unrealized
losses
   
Fair value
   
Gross
unrealized
losses
 
Noncurrent:
                               
Available-for-sale:
                               
Equity securities
  ¥ 825       178       179       13  
 


   
Yen (Millions)
 
   
December 31, 2012
 
   
Less than 12 months
   
12 months or longer
 
   
Fair value
   
Gross
unrealized
losses
   
Fair value
   
Gross
unrealized
losses
 
Noncurrent:
                               
Available-for-sale:
                               
Equity securities
  ¥ 473       33       167       19  
 
Advantest maintains non-marketable equity securities, which are recorded at cost and included in “investment securities” in the consolidated balance sheets.  The carrying amounts of non-marketable equity securities were ¥450 million and ¥450 million at March 31, 2012 and December 31, 2012, respectively.  For certain non-marketable equity securities which Advantest identified events or changes in circumstances that might have had significant adverse effect on the fair value of the investments, the fair value approximates the carrying value.  Advantest had not estimated the fair value of the majority of these non-marketable equity securities aggregating ¥50 million and ¥450 million at March 31, 2012 and December 31, 2012, respectively, since it was not practicable to estimate the fair value of the investments due to the lack of readily determinable fair values and difficulty in estimating fair value without incurring excessive cost. Non-marketable equity securities that had impairment indicators were evaluated to determine whether the investments were impaired and the impairment, if any, was other than temporary.

(6)
Derivative Financial Instruments
 
Advantest uses derivative instruments primarily to manage exposures to foreign currency. The primary objective in holding derivatives is to reduce the volatility of earnings and cash flows associated with changes in foreign currency. The instruments are not designated for trading or speculative purposes. Derivative financial instruments contain an element of risk in the event the counterparties are unable to meet the terms of the agreements. However, Advantest minimizes risk exposure by limiting the counterparties to major international banks and financial institutions meeting established credit guidelines. Management of Advantest does not expect any counterparty to default on its obligations and, therefore, does not expect to incur any losses due to counterparty default on its obligations. Advantest generally does not require or place collateral for these derivative financial instruments.
 
 
- 13 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
In accordance with U.S. GAAP, Advantest recognizes derivative instruments as either assets or liabilities on the balance sheet at fair value. Changes in fair value of the derivatives are recorded as other income (expense).
 
Derivatives not designated as hedging instruments
Derivatives not designated as hedging instruments consist primarily of forward contracts to reduce Advantest’s risk associated with exchange rate fluctuations, as gains and losses on these contracts are intended to offset exchange losses and gains on underlying exposures. Changes in fair value of foreign exchange contracts are recognized in earnings under the caption of other income (expense).

Advantest had foreign exchange contracts to exchange currencies among Japanese yen, US dollar and Euro at March 31, 2012 and December 31, 2012. The notional amounts of outstanding forward contracts for foreign currency purchases were approximately ¥653 million, and the outstanding forward contracts for foreign currency sales were ¥280 million at March 31, 2012. The notional amounts of outstanding forward contracts for foreign currency sales were ¥575 million at December 31, 2012.

Fair Value of Derivative Contracts
Fair values of derivatives not designated as hedging instruments at March 31, 2012 and December 31, 2012 were as follows:

Derivatives not designated as hedging instruments
 

   
Yen (Millions)
 
   
March 31, 2012
   
December 31, 2012
 
   
Balance Sheet
Location
   
Fair Value
   
Balance Sheet
Location
   
Fair Value
 
Assets
                               
Foreign exchange contracts
  Other current assets     ¥  21     Other current assets       16  
Liabilities
                               
Foreign exchange contracts
  Other current liabilities     ¥  0     Other current liabilities       29  


 
- 14 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
Effect of derivative instruments on the consolidated statements of operations

Derivatives not designated as hedging instruments
The effects of derivatives not designated as hedging instruments on the consolidated statements of operations for the nine months and the three months ended December 31, 2011 and 2012 were as follows:

         
Yen (Millions)
 
   
Location of
gain (loss)
recognized in
income on
derivatives
   
Amount of gain (loss) recognized in
income on derivatives
 
   
Nine months ended
December 31, 2011
   
Nine months ended
December 31, 2012
 
                         
Foreign exchange contracts   Other income (expense)     ¥ 607       (62 )

         
Yen (Millions)
 
   
Location of
gain (loss)
recognized in
income on
derivatives
   
Amount of gain (loss) recognized in
income on derivatives
 
   
Three months ended
December 31, 2011
   
Three months ended
December 31, 2012
 
                         
Foreign exchange contracts   Other income (expense)     ¥  5       (68 )
 
(7)
Fair Value Measurement
 
Disclosure about the fair value of Financial Instruments
The following table presents the carrying amounts and estimated fair values of Advantest’s financial instruments at March 31, 2012 and December 31, 2012.  Fair value estimates are made at a specific point in time based on relevant market information and information about the financial instrument.  These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision.  Changes in assumptions could significantly affect the estimates.

   
Yen (Millions)
 
   
March 31, 2012
   
December 31, 2012
 
   
Carrying
amount
   
Fair
value
   
Carrying
amount
   
Fair
value
 
Financial assets:
                       
Investment securities
                       
Available-for-sale securities
  ¥ 5,479       5,479       4,640       4,640  
Foreign exchange contracts
    21       21       16       16  
Financial liabilities:
                               
Foreign exchange contracts
    0       0       29       29  
Corporate bonds
    -       -       25,000       25,001  
 
 
- 15 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
The carrying amounts of available-for-sale securities are included in the consolidated balance sheets under investment securities.  The carrying amounts of foreign exchange contracts are included in other current assets and other current liabilities.

The following methods and assumptions are used to estimate the fair value of each class of financial instruments:

Cash and cash equivalents, trade receivables, trade accounts payable, short term debt and accrued expenses:  The carrying amounts approximate fair value because of the short maturity of these instruments.

Available-for-sale securities:  The fair values of available-for-sale equity securities are based on quoted market prices at the reporting date for those investments.

Foreign exchange contracts:  The fair value of foreign exchange contracts are estimated by obtaining quotes from financial institutions.

Corporate bonds:  The fair value of corporate bonds is estimated using market quotes and are classified as Level 2.

Fair Value Hierarchy
U.S. GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.  Additionally the inputs to valuation techniques used to measure fair value are prioritized into the following three levels:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 - Observable inputs other than quoted prices included within Level 1 for the asset or liability, either directly or indirectly.
Level 3 - Unobservable inputs for the asset or liability.

 
 
 
- 16 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
Assets / Liabilities Measured at Fair Value on a Recurring Basis
As of March 31, 2012 and December 31, 2012 carrying amount of assets and liabilities that were measured at fair value on a recurring basis by level was as follows:
 
           Yen (Millions)  
         
Fair Value Measurements
at March 31, 2012
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
                         
Assets
                       
Available-for-sale equity securities
  ¥ 5,479       5,479       -       -  
Foreign exchange contracts
    21       -       21       -  
Total assets measured at fair value
    5,500       5,479       21       -  
Liabilities
                               
Foreign exchange contracts
    0       -       0       -  
Total liabilities measured at fair value
  ¥ 0       -       0       -  

         
Yen (Millions)
 
         
Fair Value Measurements
at December 31, 2012
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
                         
Assets
                       
Available-for-sale equity securities
  ¥ 4,640       4,640       -       -  
Foreign exchange contracts
    16       -       16       -  
Total assets measured at fair value
    4,656       4,640       16       -  
Liabilities
                               
Foreign exchange contracts
    29       -       29       -  
Total liabilities measured at fair value
  ¥ 29       -       29       -  

Adjustments to fair value of available-for-sale equity securities are recorded as an increase or decrease, net of tax, in accumulated other comprehensive income (loss) except where losses are considered to be other than temporary, in which case the losses are recorded in impairment losses on investment securities. Changes in fair value of foreign exchange contracts are recorded as other income (expense).


 
- 17 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
Assets / Liabilities Measured at Fair Value on a Nonrecurring Basis
As of March 31, 2012 carrying amount of assets and liabilities, which were measured at fair value on a nonrecurring basis by level during the years ended March 31, 2012 was as follows:

         
Yen (Millions)
 
         
Fair Value Measurements
at March 31, 2012
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
                         
Assets
                       
Non-marketable equity securities
  ¥ 400       -       400       0  
Assets held for sale
    1,471       -       -       1,471  
Total assets measured at fair value
  ¥ 1,871       -       400       1,471  

For the nine months ended December 31, 2011, Advantest recognized impairment loss of ¥920 million on certain building and land included as a corporate asset that was reclassified as assets held for sale and impairment loss of ¥195 million on non-marketable equity securities when their fair values were below the carrying amounts and the decline in fair values was considered to be other than temporary.  The impairment loss was included in selling, general and administrative expenses in the accompanying consolidated statements of operations.  The fair value of the assets held for sale was reclassified to other current assets on the consolidated balance sheets.  As of December 31, 2012, Advantest reclassified certain land of ¥1,144 million as asset held for sale.  The asset held for sale was included in other current assets on the consolidated balance sheets.  As of December 31, 2012, there were no amount of assets and liabilities, which were measured at fair value on a nonrecurring basis.

The non-marketable equity securities are valued using the market and income approaches.  The fair value of non-marketable equity securities is based on quoted prices in markets that are not active at the reporting date, or present value of expected future cash flows for those investments.  The fair value of assets held for sale was determined based on a third-party appraisal using similar assets and sales and is classified as Level 3 because significant unobservable inputs were involved in the fair value measurements.


 
- 18 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 

(8)
Short Term Debt and Corporate Bonds
Short term debt at March 31, 2012 and December 31, 2012 were as follows:
   
Yen (Millions)
 
   
March 31, 2012
   
December 31, 2012
 
             
Unsecured borrowings
Weighted average annual interest 0.38%
  ¥ 25,000       -  
                 
    ¥ 25,000       -  

As of March 31, 2012, the Company had no corporate bonds. As of December 31, 2012, the amount, interest rates and maturity dates of unsecured corporate bonds were as follows:

Amount
 
Interest rate
 
Maturity date
¥10,000 million
 
0.416% per annum
 
May 25, 2015
¥15,000 million
 
0.606% per annum
 
May 25, 2017

(9)
Income Taxes
As of December 31, 2011 and 2012, the estimated annual effective tax rate for FY2011 and FY2012 differ from the 40.4 and 37.8 percent statutory income tax rate primarily due to related impacts of valuation allowance on deferred tax assets, effects of foreign income tax rates, and effects of separate company income tax reporting positions.

(10)
Stock-Based Compensation
 
In July 2012, stock options were issued to directors, corporate auditors, executive officers and employees of the Company and directors and employees of its domestic and foreign subsidiaries under a stock option plan approved by the Board of Directors.  The number of granted shares totaled 2,521,000. Options were granted with an exercise price of ¥1,207 per share that is equal to the higher of (1) 1.05 times the average price of the Company’s common shares of the preceding month on the date of grant and (2) the closing price of the Company’s common shares traded on the Tokyo Stock Exchange on the date of grant. The options have an exercise period of 4 years and are exercisable from April 1, 2013.

Stock based compensation expense recognized was ¥408 million and ¥581 million for the nine months ended December 31, 2011 and 2012, and ¥190 million and ¥290 million for the three months ended December 31, 2011 and 2012, which were included in selling, general and administrative expenses. The tax related benefits were ¥96 million and ¥161 million for the nine months ended December 31, 2011 and 2012, and ¥51 million and ¥81 million for the three months ended December 31, 2011 and 2012. As of March 31, 2012 and December 31, 2012, a valuation allowance was recorded against substantially all related deferred tax assets.


 
- 19 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 

(11) Accrued Pension and Severance Costs
 
The components of net periodic benefit cost recognized were as follows:
   
Yen (Millions)
 
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
   
Japanese
Plans
   
Non-Japanese
 Plans
   
Japanese
Plans
   
Non-Japanese
 Plans
 
                         
Service cost
  ¥ 1,011       175       1,113       291  
Interest cost
    562       169       517       253  
Expected return on plan assets
    (304 )     (167 )     (225 )     (198 )
Amortization of unrecognized:
                               
Net actuarial (gain) or loss
    384    
      593       175  
Prior service (benefit) cost
    (132 )  
      (126 )  
 
Others
    (18 )  
   
   
 
                                 
Net periodic benefit cost
  ¥ 
 1,503
      177       1,872       521  

   
Yen (Millions)
 
   
Three months ended
 
   
December 31, 2011
   
December 31, 2012
 
   
Japanese
Plans
   
Non-Japanese
 Plans
   
Japanese
Plans
   
Non-Japanese
 Plans
 
                         
Service cost
  ¥ 335       82       373       120  
Interest cost
    187       71       172       86  
Expected return on plan assets
    (101 )     (84 )     (75 )     (67 )
Amortization of unrecognized:
                               
Net actuarial (gain) or loss
    128    
      198       59  
Prior service (benefit) cost
    (44 )  
      (42 )  
 
Others
    (18 )  
   
   
 
                                 
Net periodic benefit cost
  ¥ 
 487
      69       626       198  

(12)
Dividends
Based on the resolution for the payment of year-end dividends at the Board of Directors meeting held on May 26, 2011, Advantest declared cash dividends totaling ¥866 million, or ¥5 per share of common stock on June 2, 2011 to stockholders of record on March 31, 2011.
Based on the resolution for the payment of interim dividends at the Board of Directors meeting held on October 27, 2011, Advantest declared cash dividends totaling ¥866 million, or ¥5 per share of common stock on December 1, 2011 to stockholders of record on September 30, 2011.
Based on the resolution for the payment of year-end dividends at the Board of Directors meeting held on May 30, 2012, Advantest declared cash dividends totaling ¥1,733 million, or ¥10 per share of common stock on June 4, 2012 to stockholders of record on March 31, 2012.
Based on the resolution for the payment of interim dividends at the Board of Directors meeting held on October 25, 2012, Advantest declared cash dividends totaling ¥1,735 million, or ¥10 per share of common stock on December 3, 2012 to stockholders of record on September 30, 2012.
 
 
- 20 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
(13)
Accrued Warranty Expenses
 
Advantest’s products are generally subject to warranty, and Advantest provides an allowance for such estimated costs when product revenue is recognized. To provide for future repairs during warranty periods, estimated repair expenses over the warranty period are accrued based on the historical ratio of actual repair expenses to corresponding sales, and any facts and circumstances that occurred.

Changes in accrued warranty expenses for the nine months ended December 31, 2011 and 2012 were summarized as follows:
   
Yen (Millions)
 
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
             
Balance at beginning of period
  ¥ 1,754       2,129  
Acquisition of Verigy
    205    
 
Addition
    2,494       2,268  
Reduction
    (2,292 )     (2,491 )
Translation adjustments
    (10 )     28  
                 
Balance at end of period
  ¥ 2,151       1,934  

(14)
Other income (expense)
 
Other income (expense) includes impairment losses on investment securities of ¥1,454 million and ¥109 million, and foreign exchange losses of ¥1,646 million and ¥381 million for the nine months and the three months ended December 31, 2011, respectively.
 
Other income (expense) includes impairment losses on investment securities of ¥388 million for the nine months ended December 31, 2012, and foreign exchange losses of ¥449 million and ¥475 million for the nine months and the three months ended December 31, 2012, respectively.

(15)
Operating Segment Information
 
Advantest manufactures and sells semiconductor and component test system products and mechatronics-related products such as test handlers and device interfaces.  Advantest also engages in research and development activities and provides maintenance and support services associated with these products. Advantest’s organizational structure consists of three reportable operating segments, which are the design, manufacturing, and sale of semiconductor and component test systems, mechatronics systems and services, support and others.  These reportable operating segments are determined based on the nature of the products and the markets. Segment information is prepared on the same basis that Advantest’s management reviews financial information for operational decision making purposes.
 
 
- 21 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
 
Reportable operating segment information for the nine months and three months ended December 31, 2011 and 2012 was as follows:
 
   
Yen (Millions)
 
   
Nine months ended December 31, 2011
 
   
Semiconductor
and Component
Test System
Business
   
Mechatronics
System
Business
   
Services,
Support and
Others
   
Elimination
and Corporate
   
Total
 
 Net sales to unaffiliated customers
  ¥ 67,016       14,513       13,626    
      95,155  
 Inter-segment sales
    3,267       36    
      (3,303 )  
 
Net sales
    70,283       14,549       13,626       (3,303 )     95,155  
Operating income (loss) before stock option compensation expense
    1,667       (736 )     1,149       (6,995 )     (4,915 )
Adjustment:
                                       
Stock option compensation expense
                                    408  
Operating income (loss)
                                  ¥
 (5,323)
 

   
Yen (Millions)
 
   
Nine months ended December 31, 2012
 
   
Semiconductor
and Component
Test System
Business
   
Mechatronics
System
Business
   
Services,
Support and
Others
   
Elimination
and Corporate
   
Total
 
 Net sales to unaffiliated customers
  ¥ 72,505       10,122       14,559    
      97,186  
 Inter-segment sales
    1,283       543    
      (1,826 )  
 
Net sales
    73,788       10,665       14,559       (1,826 )     97,186  
Operating income (loss) before stock option compensation expense
    9,027       (3,135 )     488       (4,975 )     1,405  
Adjustment:
                                       
Stock option compensation expense
                                    581  
Operating income (loss)
                                  ¥
824
 

 
- 22 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 

   
Yen (Millions)
 
   
Three months ended December 31, 2011
 
   
Semiconductor
and Component
Test System
Business
   
Mechatronics
System
Business
   
Services,
Support and
Others
   
Elimination
and Corporate
   
Total
 
Net sales to unaffiliated customers
  ¥ 20,352       4,472       5,871    
      30,695  
Inter-segment sales
    229       2    
      (231 )  
 
Net sales
    20,581       4,474       5,871       (231 )     30,695  
Operating income (loss) before stock option compensation expense
    (2,477 )     (415 )     1,021       (979 )     (2,850 )
Adjustment:
                                       
Stock option compensation expense
                                    190  
Operating income (loss)
                                  ¥ 
 (3,040)
 

   
Yen (Millions)
 
   
Three months ended December 31, 2012
 
   
Semiconductor
and Component
Test System
Business
   
Mechatronics
System
Business
   
Services,
Support and
Others
   
Elimination
and Corporate
   
Total
 
Net sales to unaffiliated customers
  ¥ 17,229       2,491       4,908    
      24,628  
Inter-segment sales
    121    
   
      (121 )  
 
Net sales
    17,350       2,491       4,908       (121 )     24,628  
Operating income (loss) before stock option compensation expense
    17       (1,179 )     234       (1,327 )     (2,255 )
Adjustment:
                                       
Stock option compensation expense
                                    290  
Operating income (loss)
                                  ¥
 (2,545)
 

Adjustments to operating income (loss) in Corporate principally represent corporate general and administrative expenses and research and development expenses related to fundamental research activities that are not allocated to operating segments.

Advantest uses the operating income (loss) before stock option compensation expense for management’s analysis of business segment results.
 
 
- 23 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
(16)
Per Share Data
The following table sets forth the computation of basic and diluted net income (loss) per share for the nine months and the three months ended December 31, 2011 and 2012:

   
Yen (Millions)
except share and per share data
 
   
Nine months ended
   
Nine months ended
 
   
December 31, 2011
   
December 31, 2012
 
Numerator:
           
Net income (loss)
  ¥ (7,732 )     (1,917 )
                 
Denominator:
               
Basic weighted average shares of common stock outstanding
    173,271,828       173,382,196  
Dilutive effect of exercise of stock options
 
   
 
                 
Diluted weighted average shares of common stock outstanding
    173,271,828       173,382,196  
                 
Basic net income (loss) per share
  ¥ (44.62 )     (11.05 )
Diluted net income (loss) per share
  ¥ (44.62 )     (11.05 )
                 

   
Yen (Millions)
except share and per share data
 
   
Three months ended
   
Three months ended
 
   
December 31, 2011
   
December 31, 2012
 
Numerator:
           
Net income (loss)
  ¥ (3,193 )     (3,436 )
                 
Denominator:
               
Basic weighted average shares of common stock outstanding
    173,271,756       173,536,283  
Dilutive effect of exercise of stock options
 
   
 
                 
Diluted weighted average shares of common stock outstanding
    173,271,756       173,536,283  
                 
Basic net income (loss) per share
  ¥ (18.43 )     (19.80 )
Diluted net income (loss) per share
  ¥ (18.43 )     (19.80 )
                 
 

 
 
- 24 -

 
 
ADVANTEST CORPORATION
AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (Unaudited)
 
 
At December 31, 2011 and 2012, Advantest had outstanding stock options of 5,510,768 and 6,930,162 shares of common stock, respectively, which were anti-dilutive and excluded from the calculation of diluted net income per share but could potentially dilute net income per share in future periods.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 25 -